A new test developed in the UK can accurately predict whether high-risk patients will develop bowel cancer, also known as colorectal cancer, in the five years.

Patients whose metastatic colorectal cancer has progressed following chemotherapy and who lack mutations in the RAS and BRAF ...

People with first-degree relatives who were repeatedly diagnosed with colorectal polyps appeared at increased risk for ...

A recent American Cancer Society report highlights the increasing incidence of colorectal cancer in young adults. Understanding risk factors and recognizing symptoms are crucial for early detection ...

An accurate new blood test for colon cancer, the fourth leading cause of cancer deaths in the US, has been reported.

The combination of Opdivo and Yervoy is supported by updated results as a standard of care for MSI-H or dMMR metastatic ...

In August, Illinois Gov. J.B. Pritzker signed House Bill 2385, mandating insurance coverage for all colonoscopies for patients exhibiting symptoms of colon cancer or having an existing colon condition ...

Chemotherapy has been known to cause damage to peripheral nerves, and sometimes the pain is chronic and severe enough that chemotherapy doses are reduced or discontinued. But prior research has not ...

If the blood test - from California-based biotechnology company Freenome - was approved for market, it would be one of the most accurate tests of its kind available.

A group of wedding vendors came together to throw a wedding for a Louisville family in just a matter of days after the bride learned her mother has just a few months left to live.

A simple blood test has shown promising results in accurately detecting colon cancer, a deadly disease that is rising at an ...

Roche has given two early-phase bispecifics the heave-ho, ending work on a HER2xCD3 prospect and an IL-15 candidate it picked up from Xencor. | Roche has given two early-phase bispecifics the heave-ho ...